Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Competitors to Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Abbott Laboratories ABT -5.46%
Abbott Laboratories competes with Bio-Rad primarily in the diagnostics segment, offering a diverse range of diagnostic and monitoring solutions. While Bio-Rad excels in specialty diagnostics and research instruments, Abbott has a strong foothold in point-of-care testing and clinical diagnostics. Abbott's established relationships with healthcare providers and a strong brand presence allow it to lead in market penetration, creating a competitive edge over Bio-Rad.
Agilent Technologies A -6.08%
Agilent Technologies competes with Bio-Rad in the analytical instrumentation sector, providing solutions for life sciences, diagnostics, and chemical analysis. Both companies focus on enhancing laboratory productivity and advancing scientific research. However, Agilent has a competitive advantage through its strong focus on innovation and development of cutting-edge technologies, which positions it as a leader in several high-growth market segments that overlap with Bio-Rad's offerings.
Merck Group (MilliporeSigma)
Merck Group, through its MilliporeSigma division, competes with Bio-Rad by providing a wide array of life science solutions, including laboratory supplies, reagents, and healthcare products. Both companies cater to the needs of the research community, but MilliporeSigma benefits from its strong global supply chain and strategic partnerships, giving it a competitive advantage in terms of product availability and pricing structures, which can attract customers away from Bio-Rad.
PerkinElmer
PerkinElmer competes with Bio-Rad in the fields of diagnostics, life sciences, and environmental testing. With a focus on innovative technologies and the development of integrated solutions, PerkinElmer aims to streamline the process of scientific research and diagnostics. While Bio-Rad has a solid position in specific niche markets, PerkinElmer's emphasis on technological advancements and comprehensive service offerings provides a competitive edge, allowing it to capture a significant share of the market.
Thermo Fisher Scientific TMO -6.83%
Thermo Fisher Scientific is a direct competitor to Bio-Rad Laboratories, providing a wide range of life sciences solutions including analytical instruments, reagents, and consumables used in research and clinical laboratories. Both companies focus on supplying essential tools for diagnostic testing, research, and bioproduction. Thermo Fisher has a competitive advantage due to its extensive product portfolio and global reach, allowing it to cater to a broader market and customer base compared to Bio-Rad.